Current Edition

How-Has-the-COVID-19-Pandemic-Amplified
Volume 3 Issue 3

How Has the COVID-19 Pandemic Amplified the Importance of the IVD Industry?

As the world is still coming to grips with the COVID-19 pandemic, the role of IVD in detecting, and thus helping in finding an appropriate …

Continue Reading →
DRUG DEVELOPMENT
Volume 3 Issue 3

The Benefits of Outsourcing for Early-stage Drug Development

The investment drug companies are making into producing biosimilars has never been greater. This major push is driven by the faster time to market of …

Continue Reading →
New-Wave-of-R&D-Points
Volume 3 Issue 3

New Wave of R&D Points the Way to Tackling the Oldest Enemy

The COVID-19 pandemic has forced businesses of every kind to adjust and pivot, demolishing all manner of received wisdom along the way. The changing environment …

Continue Reading →
Base Editing
Volume 3 Issue 3

Base Editing, the Story So Far

Gene editing technologies have been evolving since CRISPR was first commercialised in early 2012. The recent emergence of CRISPR base editing platforms has attracted attention …

Continue Reading →
RE-MODELLING-DRUG
Volume 3 Issue 3

Re-modelling Drug Delivery Services for High-viscosity Formulations

Biologic formulations for subcutaneous delivery allow patients to self-administer their treatment and reduce the need for them to consult hospital-based healthcare practitioners. Intravenous formulations are …

Continue Reading →